Abstract
Posterior reversible encephalopathy syndrome (PRES) is an entity characterized by the presence of variable neurological symptoms and reversible edema typically affecting the posterior white matter on brain MRI studies. It has been described in association with autoimmune diseases and with the use of chemotherapy and immunosuppressive drugs. We report a case of a 58-year-old woman with Behcet’s disease treated with methotrexate, adalimumab and low-dose prednisone who presented with sudden bilateral visual loss, together with radiological findings and clinical course suggesting PRES. PRES may appear associated with Behcet’s disease, from whose neurological complications should be differentiated, since management and prognosis differ significantly. J Med Cases. 2014;5(3):177-179 doi: http://dx.doi.org/10.14740/jmc1442w
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
